Tag: NUGN

Blue Horseshoe Stocks: New Options Ideas

Jammin Java Corp. JAMN

We’d like to radar a familiar old play that we haven’t taken a close look at in nearly a year. JAMN, over the course of the past couple of months, has tumbled its way back to bargain-basement prices.

Now a subpenny play attempting to get a leg up over newly-registered 52-week lows, we’re going to be observing the stock for a potential recovery in sessions to come, as regaining just a fraction of the ground it’s lost recently could spell multi-bag upswings from current PPS levels.

Fresh Options Ideas

We’ve got a couple of new ideas on the options trading front this morning, and based on positioning on their charts, both of the following stocks may also be ripening for possible swing-trade opportunities.

Ford Motor Co. F – In addition to a slight ascending wedge pattern, F has a sizable gap to the upside not far off of the current pricing. Additionally, short interest on the stock has decreased by a large margin, setting us up to track some potential options ideas to correspond with what we think should be some upward momentum in coming sessions.

Along with F stock itself, we’re going to be tracking the F 10/14 $12-13 Calls for possible swing trades.
__________

Freeport-McMoRan, Inc. FCX – We’re interested in this copper play for a couple reasons this morning. A huge asset sale valued at roughly $2B hitting the newswires (>>Read More) is what has drawn our attention to FCX, in conjunction with a bottom bounce signal off of 5-month support levels on the chart.

We’ll be on the lookout for chances in the FCX 10/14 $11-12 Calls. Like the previously mentioned play, time won’t be as much of a factor here, with just over a month until these contracts are set to expire.

Extended Watchlist:
KTOS, NUGN, TURV, AGTK, TPLM

Blue Horseshoe Stocks: NUGN Recap & More

NuGene International, Inc. NUGN

We came back to NUGN just in the nick of time yesterday, to start the week off on a high note. We identified the stock’s finding of support on Friday after a recent backslide, and pointed out the significance of yesterday’s PR. We postulated that the concurrence of those events could lead to a rebound on the chart, and  the stock followed our expectations to the letter.

From a low of 1.66, the it traded up to a high-of-day at 2.30; that’s an intraday pop of 39% We’ll be in the lookout for a protracted rebound out of NUGN as it attempts to regain the considerable amount of ground that it’s lost over the past month. We’ll want to see the stock maintain support at or above last Wednesday’s swing-low of 1.92 on any pullbacks in order for us to remain interested.

Pazoo, Inc. PZOO

Speaking of coming back to familiar stocks at an opportune time; we want to turn our attention back to PZOO this morning. In addition to releasing a PR containing information about the early success of wholly-owned subsidiary CannabisKing’s ‘Accuvape’ line (PR Below), the chart has reached a point where a rebound appears imminent.

As we’ve pointed out below, the stock has maintained what we’ve come to recognize as a base-level of support at .0045, and is beginning to show signs that yet another recovery is in the cards. Recent activity qualifies PZOO as a ‘Double Bottom’ (>>Investopedia Definition) which lends support to that conclusion. We’ll be watching the trading action in PZOO heavily this week as a result.

WHIPPANY, N.J., Aug. 18, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks: PZOO), is pleased to report that 100% wholly owned subsidiary CannabisKing Distribution, LLC, in just one week after training, completes multiple sales for the AccuVape product line in Nevada, Colorado, New Jersey and New York. After such an initial sales success, CannabisKing has lined up dozens of sales calls over the next few weeks, most from new client referrals.  CannabisKing is confident they will be able to introduce the AccuVape line to a larger market share, nationally. >>VIEW FULL PR

Tesla Motors, Inc. TSLA – Options Update

Yesterday we identified potential intraday and/or intraweek trading opportunities in TSLA Weekly $250-265 Calls. We’ll be monitoring that range consistently over the course of the week, and saw the first significant action yesterday in the $250 and $252.50’s:

$250 Calls – Range: 5.09-7.70 – Max Gain: 51%
$252.50 Calls – Range: 3.89-5.92 – Max Gain: 52%

Extended Watchlist:
OMER(Big-Gapper)

Blue Horseshoe Stocks: Fresh News Plays & More

Fresh News Plays

We’ve got a couple of stocks that we’ve been tracking this summer coming out with noteworthy press in the early hours this morning, we’re going to want to increase our alertness level for each of them as we kick off a new trading week.

NuGene International, Inc. NUGN –  NUGN is appearing in the news feed with a substantial revelation at an opportune time this morning. The stock took an absolute beating last week, and just began to find its footing off of a previous support level on Friday. At the moment the stock is extremely oversold. Coupling that with the addition of this morning’s PR announcing the company’s Q2 revenue growth of more than 150% over the prior year, conditions could be just right for a rebound. We’ll be on a sharp lookout for that possibility.

___

AVEO Pharmaceuticals, Inc. AVEO

AVEO stock is gapping up immensely in premarket trading on the strength of a deal the company just announced with Novartis. The potential for both a momentum play and/or a bounce play is elevated. We’ll need to see it maintain support at or above 2.20 (a previous resistance point) on any pullbacks to remain interested. With high profile news like this, it’s quite possible that it will do so.

AVEO Oncology (AVEO) today announced an exclusive, worldwide license agreement with Novartis for the development and commercialization of AVEO’s first-in-class, potent, humanized inhibitory antibody targeting growth differentiation factor 15 (GDF15), AV-380, and related antibodies>>>Full PR

Tesla Motors, Inc. TSLA – Options Idea

We’d like to submit a potential options trading idea to start the week. Morgan Stanley has raised their price target on the stock (Currently valued in the mid-$250’s) from $280 to $465, and TSLA is gapping up on the heels of that announcement. As a result, we see the potential for some intraday and/or intraweek trading opportunities in the range of TSLA Weekly $250-265 Calls.

Extended Watchlist:
ZU(Gapping Up), SFXE & XGTI(Both Oversold, on Bottom Watch)